INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 196 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $624,000 | -29.4% | 42,049 | -5.0% | 0.00% | -25.0% |
| Q2 2021 | $884,000 | +37.9% | 44,259 | +59.5% | 0.00% | +33.3% |
| Q1 2021 | $641,000 | -35.1% | 27,753 | -30.6% | 0.00% | -25.0% |
| Q4 2020 | $988,000 | +51.5% | 40,017 | +154.4% | 0.00% | +33.3% |
| Q3 2020 | $652,000 | -34.3% | 15,730 | -24.1% | 0.00% | -40.0% |
| Q2 2020 | $993,000 | +5.3% | 20,719 | +38.3% | 0.01% | -16.7% |
| Q1 2020 | $943,000 | -49.2% | 14,980 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $1,856,000 | +278.0% | 14,980 | +102.4% | 0.01% | +200.0% |
| Q3 2019 | $491,000 | +102.9% | 7,400 | +142.9% | 0.00% | +200.0% |
| Q2 2019 | $242,000 | -29.4% | 3,047 | -0.7% | 0.00% | -50.0% |
| Q1 2019 | $343,000 | -49.6% | 3,067 | +6.6% | 0.00% | -71.4% |
| Q2 2014 | $681,000 | – | 2,877 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |